Literature DB >> 18840248

Human subjects protections in biomedical enhancement research: assessing risk and benefit and obtaining informed consent.

Maxwell J Mehlman1, Jessica W Berg.   

Abstract

The protection of human subjects in biomedical research relies on two principal mechanisms: assessing and comparing the risks and potential benefits of proposed research, and obtaining potential subjects' informed consent. While these have been discussed extensively in the literature, no attention has been paid to whether the processes should be different when the objective of an experimental biomedical intervention is to improve individual appearance, performance, or capability ("enhancement research") rather than to prevent, cure, or mitigate disease ("health-oriented research"). This essay examines this question in order to ensure that subjects in biomedical enhancement research receive adequate protection.

Entities:  

Mesh:

Year:  2008        PMID: 18840248      PMCID: PMC3711218          DOI: 10.1111/j.1748-720X.2008.303.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  33 in total

1.  What makes clinical research ethical?

Authors:  E J Emanuel; D Wendler; C Grady
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

2.  Human nature technologically revisited.

Authors:  H Tristram Engelhardt
Journal:  Soc Philos Policy       Date:  1990

3.  The therapeutic orientation to clinical trials.

Authors:  Franklin G Miller; Donald L Rosenstein
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

Review 4.  Position statement on human aging.

Authors:  S Jay Olshansky; Leonard Hayflick; Bruce A Carnes
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-08       Impact factor: 6.053

5.  A simple way to choose the right implant volume in breast augmentation.

Authors:  Roberto Bracaglia; And Regina Fortunato; Stefano Gentileschi
Journal:  Aesthetic Plast Surg       Date:  2005 Sep-Oct       Impact factor: 2.326

Review 6.  Justice, fairness, and enhancement.

Authors:  Julian Savulescu
Journal:  Ann N Y Acad Sci       Date:  2006-12       Impact factor: 5.691

Review 7.  Clinical trials of xenotransplantation: waiver of the right to withdraw from a clinical trial should be required.

Authors:  Monique A Spillman; Robert M Sade
Journal:  J Law Med Ethics       Date:  2007       Impact factor: 1.718

8.  Assessing research risks systematically: the net risks test.

Authors:  D Wendler; F G Miller
Journal:  J Med Ethics       Date:  2007-08       Impact factor: 2.903

9.  Feeling better? Trends in general health status.

Authors:  Linda G Martin; Robert F Schoeni; Vicki A Freedman; Patricia Andreski
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2007-01       Impact factor: 4.077

10.  Is better always good? The Enhancement Project.

Authors:  E Parens
Journal:  Hastings Cent Rep       Date:  1998 Jan-Feb       Impact factor: 2.683

View more
  1 in total

1.  Generating genius: how an Alzheimer's drug became considered a 'cognitive enhancer' for healthy individuals.

Authors:  Lucie Wade; Cynthia Forlini; Eric Racine
Journal:  BMC Med Ethics       Date:  2014-05-12       Impact factor: 2.652

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.